Value Based Pricing | List of Frontiers open access articles

Original Research

Published on 24 Jun 2024

Unraveling elements of value-based pricing from a pharmaceutical industry’s perspective: a scoping review

in Drugs Outcomes Research and Policies

Aniek Dane
Carin Uyl-de Groot
Hugo van der Kuy

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1298923

8,280 views
3 citations

Perspective

Published on 09 Sep 2020

Getting the Right Evidence After Drug Approval

in Drugs Outcomes Research and Policies

Rick A. Vreman
Hubert G. M. Leufkens
Aaron S. Kesselheim

Frontiers in Pharmacology

doi 10.3389/fphar.2020.569535

4,427 views
12 citations

Original Research

Published on 01 Jun 2016

Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs

in Drugs Outcomes Research and Policies

Kim Pauwels
Isabelle Huys
Minne Casteels
Steven Simoens

Frontiers in Pharmacology

doi 10.3389/fphar.2016.00144

11,784 views
9 citations

Review

Published on 13 Feb 2023

Recent advances in addressing the market failure of new antimicrobials: Learnings from NICE's subscription-style payment model

in Regulatory Affairs

Marieke Schurer
Renu Patel
Marjolijn van Keep
Jake Horgan
Suzette Matthijsse
Matthew Madin-Warburton

Frontiers in Medical Technology

doi 10.3389/fmedt.2023.1010247

5,655 views
5 citations

Perspective

Published on 24 Sep 2024

Escalating costs of innovative medicines: perspective and proposals

in Health Economics

Antonio Vallano
Caridad Pontes

Frontiers in Public Health

doi 10.3389/fpubh.2024.1449707

6,064 views
13 citations

Original Research

Published on 02 May 2023

Livestock feed markets across agro-ecological zones of Burkina Faso: feed provenance, price and quality

in Animal Nutrition

Augustine A. Ayantunde
Tunde Amole
Alan J. Duncan

Frontiers in Animal Science

doi 10.3389/fanim.2023.1122416

3,943 views
8 citations

Policy and Practice Reviews

Published on 05 Nov 2025

Driving the future of value-based healthcare in the Gulf Cooperation Council: a roadmap for achieving sustainable access to specialty pharmaceuticals

in Public Health Policy

Anas Hamad
Ahmed Al-Jedai
Rita Ojeil
Abdulrazaq Sheikh Al-Jazairi
Adel AlAssy
Yazed S. AlRuthia
Waiel Al Naeem
Hajer Almudaiheem
Mouza Alsaadi
Nada Alagil

Frontiers in Public Health

doi 10.3389/fpubh.2025.1667846

4,434 views

Original Research

Published on 05 Mar 2018

An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries

in Health Economics

Maria Kamusheva
Mariya Vassileva
Alexandra Savova
Manoela Manova
Guenka Petrova

Frontiers in Public Health

doi 10.3389/fpubh.2018.00061

7,312 views
4 citations

Original Research

Published on 14 Aug 2025

Beyond efficacy parity: a novel cost-equilibrium framework for value assessment of competing third-line therapies in metastatic colorectal cancer

in Drugs Outcomes Research and Policies

Shunlong Ou
Bingjie Wang
Jing Luo
Qian Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1606742

1,951 views

Articles

Unraveling elements of value-based pricing from a pharmaceutical industry’s perspective: a scoping review

Getting the Right Evidence After Drug Approval

Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs

Recent advances in addressing the market failure of new antimicrobials: Learnings from NICE's subscription-style payment model

Escalating costs of innovative medicines: perspective and proposals

Livestock feed markets across agro-ecological zones of Burkina Faso: feed provenance, price and quality

Driving the future of value-based healthcare in the Gulf Cooperation Council: a roadmap for achieving sustainable access to specialty pharmaceuticals

An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries

Beyond efficacy parity: a novel cost-equilibrium framework for value assessment of competing third-line therapies in metastatic colorectal cancer